المؤلفون: Chan, Arlene, Moy, Beverly, Mansi, Janine, Ejlertsen, Bent, Holmes, Frankie Ann, Chia, Stephen, Iwata, Hiroji, Gnant, Michael, Loibl, Sibylle, Barrios, Carlos H, Somali, Isil, Smichkoska, Snezhana, Martinez, Noelia, Alonso, Mirta Garcia, Link, John S, Mayer, Ingrid A, Cold, Søren, Murillo, Serafin Morales, Senecal, Francis, Inoue, Kenichi, Ruiz-Borrego, Manuel, Hui, Rina, Denduluri, Neelima, Patt, Debra, Rugo, Hope S, Johnston, Stephen R D, Bryce, Richard, Zhang, Bo, Xu, Feng, Wong, Alvin, Martin, Miguel, ExteNET Study Group

المصدر: ExteNET Study Group 2021, ' Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial ', Clinical Breast Cancer, vol. 21, no. 1, pp. 80-91.e7 . https://doi.org/10.1016/j.clbc.2020.09.014Test
Chan, A, Moy, B, Mansi, J, Ejlertsen, B, Holmes, F A, Chia, S, Iwata, H, Gnant, M, Loibl, S, Barrios, C H, Somali, I, Smichkoska, S, Martinez, N, Alonso, M G, Link, J S, Mayer, I A, Cold, S, Murillo, S M, Senecal, F, Inoue, K, Ruiz-Borrego, M, Hui, R, Denduluri, N, Patt, D, Rugo, H S, Johnston, S R D, Bryce, R, Zhang, B, Xu, F, Wong, A, Martin, M & ExteNET Study Group 2021, ' Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial ', Clinical Breast Cancer, vol. 21, no. 1, pp. 80-91.e7 . https://doi.org/10.1016/j.clbc.2020.09.014Test

مصطلحات موضوعية: Adult, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Distant disease-free survival, Receptor, ErbB-2, Disease-free survival, medicine.medical_treatment, Population, Breast Neoplasms, Placebo, Gastroenterology, Adjuvant therapy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Double-Blind Method, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Overall survival, education, Neoadjuvant therapy, Neoplasm Staging, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Hazard ratio, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Neratinib, Quinolines, Female, business, Follow-Up Studies, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9af8dc5d2e7a7a6d4d1c8bee844afef3Test
https://curis.ku.dk/portal/da/publications/final-efficacy-results-of-neratinib-in-her2positive-hormone-receptorpositive-earlystage-breast-cancer-from-the-phase-iii-extenet-trialTest(1ad6c398-84d3-4a5f-9980-40fc5741d3ce).html

المؤلفون: Rajasingham, Radha, Bangdiwala, Ananta S, Nicol, Melanie R, Skipper, Caleb P, Pastick, Katelyn A, Axelrod, Margaret L, Pullen, Matthew F, Nascene, Alanna A, Williams, Darlisha A, Engen, Nicole W, Okafor, Elizabeth C, Rini, Brian I, Mayer, Ingrid A, McDonald, Emily G, Lee, Todd C, Li, Peter, MacKenzie, Lauren J, Balko, Justin M, Dunlop, Stephen J, Hullsiek, Katherine H, Boulware, David R, Lofgren, Sarah M, Abassi, Mahsa, Balster, Andrew, Collins, Lindsey B, Drobot, Glen, Krakower, Douglas S, Lother, Sylvain A, MacKay, Dylan S, Meyer-Mueller, Cameron, Selinsky, Stephen, Solvason, Dayna, Zarychanski, Ryan, Zash, Rebecca

المصدر: Clinical Infectious Diseases
Clin Infect Dis

مصطلحات موضوعية: 0301 basic medicine, Microbiology (medical), Canada, medicine.medical_specialty, Health Personnel, Placebo, Loading dose, law.invention, 03 medical and health sciences, Pre-exposure prophylaxis, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Intensive care, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Online Only Articles, SARS-CoV-2, business.industry, Hydroxychloroquine, COVID-19 Drug Treatment, Clinical trial, 030104 developmental biology, Infectious Diseases, Pre-Exposure Prophylaxis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05207a67badcf365ef322c99f670dd64Test

المؤلفون: Sparano, Joseph A., Gray, Robert J., Ravdin, Peter M., Makower, Della F., Pritchard, Kathleen I., Albain, Kathy S., Hayes, Daniel F., Geyer, Charles E., Dees, Elizabeth C., Goetz, Matthew P., Olson, John A., Lively, Tracy, Badve, Sunil S., Saphner, Thomas J., Wagner, Lynne I., Whelan, Timothy J., Ellis, Matthew J., Chir, B., Paik, Soonmyung, Wood, William C., Keane, Maccon M., Gomez Moreno, Henry L., Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Brufsky, Adam M., Kaklamani, V.G., Toppmeyer, Deborah L., Kaklamani, Virginia G., Berenberg, Jeffrey L., Abrams, Jeffrey, Sledge, George W.

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Antineoplastic Agents, Hormonal, Receptor, ErbB-2, medicine.medical_treatment, Breast Neoplasms, 030204 cardiovascular system & hematology, Disease-Free Survival, Article, law.invention, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Randomized controlled trial, law, Risk Factors, Internal medicine, medicine, Adjuvant therapy, Humans, 030212 general & internal medicine, Prospective Studies, Prospective cohort study, Aged, Proportional Hazards Models, Chemotherapy, Proportional hazards model, business.industry, Gene Expression Profiling, Age Factors, Estrogen Antagonists, General Medicine, Middle Aged, medicine.disease, Prognosis, Tamoxifen, Premenopause, Chemotherapy, Adjuvant, Female, Neoplasm Recurrence, Local, business, Adjuvant, Algorithms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a7f565b375f044e705c91d88c3edbbTest
https://europepmc.org/articles/PMC6709671Test/

المؤلفون: Nikhil Wagle, Weiyi Toy, Monica Rizzo, Eliezer M. Van Allen, Thomas Stricker, Jason Christiansen, Vincent A. Miller, Violeta Sanchez, Maria G. Kuba, Xinmeng J. Mu, Carlos L. Arteaga, Jennifer M. Giltnane, Erica L. Mayer, Ingrid M. Meszoely, Liping Du, Henry Gόmez, Kai Wang, Phillip J. Stephens, Monica V. Estrada, Paula Gonzalez Ericsson, Vandana G. Abramson, Kerry Fitzgerald, Danielle Murphy, Levi A. Garraway, Justin M. Balko, Mellissa J. Nixon, Luigi Formisano, Roman Yelensky, Yu Shyr, Ingrid A. Mayer, Melinda E. Sanders, Christian D. Young, Katherine E. Hutchinson, Jeffrey S. Ross, Sarat Chandarlapaty

المساهمون: Giltnane, Jennifer M., Hutchinson, Katherine E., Stricker, Thomas P., Formisano, Luigi, Young, Christian D., Estrada, Monica V., Nixon, Mellissa J., Du, Liping, Sanchez, Violeta, Ericsson, Paula Gonzalez, Kuba, Maria G., Sanders, Melinda E., Mu, Xinmeng J., Van Allen, Eliezer M., Wagle, Nikhil, Mayer, Ingrid A., Abramson, Vandana, Gómez, Henry, Rizzo, Monica, Toy, Weiyi, Chandarlapaty, Sarat, Mayer, Erica L., Christiansen, Jason, Murphy, Danielle, Fitzgerald, Kerry, Wang, Kai, Ross, Jeffrey S., Miller, Vincent A., Stephens, Phillip J., Yelensky, Roman, Garraway, Levi, Shyr, Yu, Meszoely, Ingrid, Balko, Justin M., Arteaga, Carlos L.

المصدر: Science Translational Medicine. 9

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Aromatase inhibitor, biology, Cyclin-dependent kinase 4, medicine.drug_class, Letrozole, Oncology, drug resistance, Estrogen Receptor, Breast Cancer, General Medicine, Cell cycle, 03 medical and health sciences, 030104 developmental biology, Cyclin D1, Endocrinology, Estrogen, Internal medicine, biology.protein, medicine, Cancer research, Cyclin-dependent kinase 6, Estrogen receptor alpha, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d9715b2b0508c88e79fd618cd6ac3cTest
https://doi.org/10.1126/scitranslmed.aai7993Test

المؤلفون: Valerie M. Jansen, Yao Lu, Stefano Cairo, Thomas Stricker, Carlos L. Arteaga, Luis J. Schwarz, Justin M. Balko, Jennifer M. Giltnane, Angel Guerrero-Zotano, Monica M. Estrada, Roberto Bianco, Neil E. Bhola, Jean Gabriel Judde, Kimberly M. Stauffer, Ingrid A. Mayer, Melinda E. Sanders, Christian D. Young, Luigi Formisano, Olivier Deas, Katherine E. Hutchinson, Teresa C. Dugger

المساهمون: Formisano, Luigi, Stauffer, Kimberly Mae, Young, Christian D, Bhola, Neil E, Guerrero Zotano, Angel L, Jansen, Valerie M, Estrada, Monica M, Hutchinson, Katherine E, Giltnane, Jennifer M, Schwarz, Luis J, Lu, Yao, Balko, Justin M, Deas, Olivier, Cairo, Stefano, Judde, Jean Gabriel, Mayer, Ingrid A, Sanders, Melinda, Dugger, Teresa C, Bianco, Roberto, Stricker, Thoma, Arteaga, Carlos L.

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Transcription, Genetic, medicine.drug_class, Cell, Breast Neoplasms, Biology, Tyrosine-kinase inhibitor, 03 medical and health sciences, Mice, 0302 clinical medicine, Estrogen Receptor Modulators, Internal medicine, Cell Line, Tumor, medicine, Animals, Humans, Molecular Targeted Therapy, Receptor, Fibroblast Growth Factor, Type 1, E2F, Protein Kinase Inhibitors, Neoplasm Staging, Fulvestrant, Cell growth, Letrozole, Estrogen Receptor alpha, Gene Amplification, Fibroblast Growth Factors, Gene Expression Regulation, Neoplastic, stomatognathic diseases, Disease Models, Animal, Protein Transport, FGFR1, breast cancer, estrogen resistance, 030104 developmental biology, Endocrinology, medicine.anatomical_structure, Oncology, Estrogen, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, Female, Estrogen receptor alpha, medicine.drug, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82328de40882b87c5d6dfa5142c7893Test
http://hdl.handle.net/11588/682039Test

المؤلفون: Monica V. Estrada, Dejan Juric, Carlos L. Arteaga, Luigi Formisano, Lewis C. Cantley, David B. Solit, Helen Won, Melinda E. Sanders, Michael F. Berger, Yisheng Li, Justin M. Balko, Vandana G. Abramson, Ingrid A. Mayer, Eric P. Winer

المساهمون: Mayer, Ingrid A., Abramson, Vandana G., Formisano, Luigi, Balko, Justin M., Estrada, Mónica V., Sanders, Melinda E., Juric, Dejan, Solit, David, Berger, Michael F., Won, Helen H., Li, Yisheng, Cantley, Lewis C., Winer, Eric, Arteaga, Carlos L.

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, DNA Mutational Analysis, medicine.disease_cause, Phosphatidylinositol 3-Kinases, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, In Situ Hybridization, Fluorescence, Phosphoinositide-3 Kinase Inhibitors, Aromatase Inhibitors, Letrozole, Middle Aged, Metastatic breast cancer, Neoplasm Metastasi, Treatment Outcome, Tolerability, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, KRAS, Nitrile, Breast Neoplasm, medicine.drug, Human, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Breast Neoplasms, Article, DNA Mutational Analysi, 03 medical and health sciences, Breast cancer, Internal medicine, Cell Line, Tumor, Nitriles, medicine, Biomarkers, Tumor, Aromatase Inhibitor, Humans, Receptor, Fibroblast Growth Factor, Type 1, Adverse effect, neoplasms, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, Cancer, Triazoles, medicine.disease, Clinical trial, Thiazoles, 030104 developmental biology, Endocrinology, Mutation, Triazole, Phosphatidylinositol 3-Kinase, Thiazole, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8336724711550ce626edc119aec5689dTest
https://europepmc.org/articles/PMC5085926Test/